pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 4·1 min read
save

Elevance Health’s chief digital officer discusses practical AI applications for insurers

Jun 4, 2026·read at Endpoints ↗Neutral

Elevance Health interviewed its chief digital information officer, Ratnakar Lavu, about how health insurers are adopting artificial intelligence.

Lavu, who previously held digital roles at Kohl’s, Nike and Macy’s, says his retail background informs the way Elevance approaches AI, focusing on tools that deliver measurable benefits.

He stresses that the company is pursuing practical AI solutions that streamline operations and improve member experiences, rather than chasing hype.

The conversation underscores the pressure on insurers to keep pace with AI advances in order to stay competitive in the market.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Elevance talks 'practical' AI”

read at Endpoints ↗
77 words · retrieved Jun 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoOMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorderEndpoints
  • 13h agoSanofi's new R&D chief: Western pharma should rethink China's drug pipeline roleEndpoints
  • 13h agoNew FDA framework tilts toward consistency over flexibilityEndpoints
  • 16h agoVerastem makes its stand as a RevMed competitor in pancreatic cancerEndpoints
  • 17h agoUltragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slumpEndpoints